Patent 7285640 was granted and assigned to Bayer Corporation on October, 2007 by the United States Patent and Trademark Office.
The present invention provides human antibodies specific for stem cell factor that contain at least one CDR derived from a combinatorial antibody library. The invention also provides pharmaceutical compositions comprising the antibodies and methods of treating asthma. The invention further provides methods of detecting stem cell factor using the antibodies.